Close Menu

The Times Online reports that a new company based in Boston, Foundation Medicine, has raised $25 million to develop a "one-stop-shop service for genomic diagnosis of cancer." The company's founders include Broad Institute director Eric Lander as well as Levi Garraway, Matthew Meyerson, and Todd Golub of the Dana Farber Cancer Institute and Harvard Medical School, the paper reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.